{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05755490",
            "orgStudyIdInfo": {
                "id": "22-609"
            },
            "organization": {
                "fullName": "Massachusetts General Hospital",
                "class": "OTHER"
            },
            "briefTitle": "PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention",
            "officialTitle": "PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "prowess-prostate-cancer-wearables-exercise-and-structured-supports-a-pilot-supportive-care-intervention"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-02",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-13",
            "studyFirstSubmitQcDate": "2023-02-22",
            "studyFirstPostDateStruct": {
                "date": "2023-03-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-02-22",
            "lastUpdatePostDateStruct": {
                "date": "2023-03-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Daniel E Lage, MD, MSc",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Massachusetts General Hospital"
            },
            "leadSponsor": {
                "name": "Massachusetts General Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this research study is to conduct an open pilot of a behavioral change intervention called PROstate Cancer Wearables, Exercise, and Structured Supports (PROWESS) for integrating health behavior change tools and to increase exercise, reduce side effects of androgen deprivation therapy (ADT), and improve quality of life in Black and Hispanic/Latino men with prostate cancer.\n\nThe name of the intervention used in this research study is:\n\nPROWESS (behavioral change intervention)",
            "detailedDescription": "This research study is to test a behavioral change intervention called PROstate Cancer Wearables, Exercise, and Structured Supports (PROWESS) for integrating health behavior change tools with wearable technology, to increase exercise, reduce side effects of androgen deprivation therapy (ADT), and improve quality of life in Black and Hispanic/Latino men with prostate cancer on androgen deprivation therapy (ADT).\n\nStudy procedures include screening for eligibility, intervention sessions, questionnaires and surveys, and an exit interview with study staff.\n\nParticipation in this research study is expected to last for up to four months.\n\nThe goal and primary outcome of this open pilot study is refinement of the intervention and study procedures to allow for us to conduct a larger feasibility study in the future.\n\nIt is expected that about 10 people will take part in this research study.\n\nThis research study is being supported by the MGH Cancer Center"
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer",
                "Prostatic Neoplasms"
            ],
            "keywords": [
                "Prostate Cancer",
                "Prostatic Neoplasms",
                "Androgen Deprivation Therapy",
                "ADT",
                "CBR",
                "Cognitive Behavioral Therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "PROWESS",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will complete study procedures as outlined:\n\n* Wear FitBit watch during the 12-week study period.\n* Group intervention sessions, in-person or virtually.\n* Two, optional follow-up sessions.\n* One-on-one, semi-structured interview with trained study staff to assess participant experience with intervention.",
                    "interventionNames": [
                        "Behavioral: PROWESS"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "PROWESS",
                    "description": "Structured, culturally sensitive behavior change intervention comprised of six video-based or in-person sessions with psychologist or social worker. FitBit is provided by study.",
                    "armGroupLabels": [
                        "PROWESS"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Participant Satisfaction",
                    "description": "Assessed by the Client Satisfaction Questionnaire-3 (CSQ), a 3-item survey with answers ranging from 1-4, \"quite dissatisfied\" to \"very satisfied.\"",
                    "timeFrame": "At week 12-14 (intervention completion)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Objective Physical Activity",
                    "description": "Collected physical activity via FitBit measure of steps and activity classification.",
                    "timeFrame": "At Baseline and from weeks 6 - 14"
                },
                {
                    "measure": "Change in Self-Reported Exercise",
                    "description": "Assessed by the International Physical Activity Questionnaire (IPAQ), a 27-item self-reported measure of physical activity.",
                    "timeFrame": "At Baseline and weeks 12-14"
                },
                {
                    "measure": "Change in Participant Quality of Life",
                    "description": "Assessed by the Functional Assessment of Cancer Therapy-Prostate (FACT-P), which consists of five subscales assessing physical, functional, emotional, social wellbeing.",
                    "timeFrame": "At Baseline and weeks 12-14"
                },
                {
                    "measure": "Change in Participant Distress",
                    "description": "Assessed by the Hospital Anxiety and Depression scale (HADS), a 14-item measure with two separate subscales to evaluate symptoms of anxiety and depression.",
                    "timeFrame": "At Baseline and weeks 12-14"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with prostate cancer.\n* Has been on androgen deprivation therapy (ADT) for at least three months, and planned to continue ADT as of last clinic visit.\n* Black Race AND/OR Hispanic/Latino Ethnicity (confirmed by patient self-report)\n* Verbal fluency in English or Spanish.\n* Receiving ongoing oncology care at MGH Cancer Center.\n* Age \u2265 18 years.\n* Self-Report less than or equal to 150 minutes of moderate or vigorous structured exercise per week, as assessed by the Exercise is Medicine Physical Activity Vital Sign Assessment.\n* Access to a smartphone or a computer with USB Bluetooth adapter.\n\nExclusion Criteria:\n\n* Unwilling or unable to participate in the study.\n* Significant psychiatric, cognitive or other comorbid disease which the treating clinician believes prohibits informed consent or participation in the study.\n* Currently receiving chemotherapy.\n* Prognosis less than 6 months, per the judgment of the primary oncologist.\n* Medical contraindication to physical activity, as assessed by outpatient oncologist.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "genderBased": true,
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Daniel Lage, MD",
                    "role": "CONTACT",
                    "phone": "617-726-5130",
                    "email": "dlage@partners.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Daniel Lage, MD",
                    "affiliation": "Massachusetts General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital Cancer Center",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniel Lage, MD",
                            "role": "CONTACT",
                            "phone": "617-726-5130",
                            "email": "dlage@partners.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \\[contact information for Sponsor Investigator or designee\\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF"
            ],
            "timeFrame": "Data can be shared no earlier than 1 year following the date of publication",
            "accessCriteria": "Contact the Partners Innovations team at http://www.partners.org/innovation"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4059",
                    "name": "Androgens",
                    "relevance": "LOW"
                },
                {
                    "id": "M17752",
                    "name": "Yohimbine",
                    "relevance": "LOW"
                },
                {
                    "id": "T332",
                    "name": "Yohimbe",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Urol",
                    "name": "Urological Agents"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                }
            ]
        }
    },
    "hasResults": false
}